Colonic mucosal expression of cell adhesion molecule 1 (CADM1) increases alongside disease activity in patients with ulcerative colitis, according to findings from a retrospective single-center study. Investigators evaluated mucosal tissue samples to determine whether CADM1 could serve as a candidate tissue-associated indicator of localized inflammatory severity in the colon.
Accurately assessing mucosal inflammatory activity remains essential for managing ulcerative colitis. Although CADM1 is known to participate in epithelial organization and interactions with immune cells, its specific relationship with mucosal inflammation in ulcerative colitis had previously remained unclear, prompting researchers to examine its presence across varying stages of active disease.
The investigation analyzed colonic mucosal specimens obtained from 108 participants, consisting of 13 control individuals and 95 patients diagnosed with ulcerative colitis. Clinical severity among the ulcerative colitis cohort was classified endoscopically using the Ulcerative Colitis Endoscopic Index of Severity, while microscopic inflammation was evaluated through the Nancy histological index.
To measure tissue markers directly, the research team detected CADM1, phosphorylated signal transducer and activator of transcription 3 (p-STAT3), and CD11c using immunohistochemical staining. Marker levels across tissue sections were subsequently quantified with digital image analysis using QuPath software before statistical evaluation.
Measurements revealed that tissue levels of CADM1, p-STAT3, and CD11c increased consistently with disease activity. Statistical testing demonstrated positive correlations between CADM1 and the Ulcerative Colitis Endoscopic Index of Severity, the modified Mayo score, the Nancy histological index, C-reactive protein, erythrocyte sedimentation rate, p-STAT3, and CD11c. Conversely, CADM1 levels showed an inverse correlation with serum albumin concentrations.
In multivariable binary logistic regression models adjusted for participant age, sex, disease duration, disease extent, and pre-endoscopy treatment exposure, natural log-transformed CADM1 maintained a statistically significant association with moderate-to-severe disease. Receiver operating characteristic analyses showed an area under the curve of 0.937 for CADM1 alone in distinguishing mild from moderate-to-severe ulcerative colitis, which reached 0.951 when combining CADM1, p-STAT3, and CD11c. External transcriptomic validations using public Gene Expression Omnibus datasets GSE87466 and GSE75214 confirmed CADM1 upregulation alongside STAT3, SOCS3, IL6, and TNF.
The study concluded that CADM1 is elevated in ulcerative colitis colonic mucosa and corresponds with clinical, endoscopic, histological, and systemic inflammation, alongside p-STAT3 activation and CD11c-positive cell infiltration. The authors noted that CADM1 represents a candidate marker of mucosal activity, though prospective multicenter evaluations and independent validations remain necessary before any routine clinical adoption.
Subject of Research: Evaluation of mucosal CADM1 expression as a marker of inflammatory activity in ulcerative colitis
Article Title: Association of CADM1 expression with inflammatory activity in ulcerative colitis: a retrospective single-center study
Article References: Luo, Z., Wang, D., Ma, H., Tan, J., Liang, J., Wang, R., & Xu, C. (2026). Association of CADM1 expression with inflammatory activity in ulcerative colitis: a retrospective single-center study. BMC Gastroenterology. https://doi.org/10.1186/s12876-026-05583-x
Image Credits: AI Generated
DOI: 10.1186/s12876-026-05583-x
Keywords: CADM1, ulcerative colitis, mucosal inflammation, UCEIS, Nancy histological index, immunohistochemistry, QuPath, p-STAT3, CD11c, biomarkers, ROC analysis, GSE87466, GSE75214, endoscopy, C-reactive protein, erythrocyte sedimentation rate, colonic mucosa
News Source: Ophelia Keating. (November 20, 2026). Colonic CADM1 Expression Correlates With Ulcerative Colitis Mucosal Inflammatory Activity. Scienmag.



